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o r i g i n a l a r t i c l e
Developing a Risk Stratification Model for Surgical Site Infection
after Abdominal Hysterectomy
Margaret A. Olsen, PhD, MPH; James Higham-Kessler, BA; Deborah S. Yokoe, MD; Anne M. Butler, MS;
Johanna Vostok, BS; Kurt B. Stevenson, MD, MPH; Yosef Khan, MBBS, MPH; Victoria J. Fraser, MD,
for the Prevention Epicenter Program, Centers for Disease Control and Prevention
objective. The incidence of surgical site infection (SSI) after hysterectomy ranges widely from 2% to 21%. A specific risk stratification
index could help to predict more accurately the risk of incisional SSI following abdominal hysterectomy and would help determine the
reasons for the wide range of reported SSI rates in individual studies. To increase our understanding of the risk factors needed to build a
specific risk stratification index, we performed a retrospective multihospital analysis of risk factors for SSI after abdominal hysterectomy.
methods. Retrospective case-control study of 545 abdominal and 275 vaginal hysterectomies from July 1, 2003, to June 30, 2005, at 4
institutions. SSIs were defined by using Centers for Disease Control and Prevention/National Nosocomial Infections Surveillance criteria.
Independent risk factors for abdominal hysterectomy were identified by using logistic regression.
results. There were 13 deep incisional, 53 superficial incisional, and 18 organ-space SSIs after abdominal hysterectomy and 14 organ-
space SSIs after vaginal hysterectomy. Because risk factors for organ-space SSI were different according to univariate analysis, we focused
further analyses on incisional SSI after abdominal hysterectomy. The maximum serum glucose level within 5 days after operation was
highest in patients with deep incisional SSI, lower in patients with superficial incisional SSI, and lowest in uninfected patients (median,
189, 156, and 141 mg/dL, respectively; ). Independent risk factors for incisional SSI included blood transfusion (odds ratio [OR],Pp .005
2.4) and morbid obesity (body mass index [BMI], 135; OR, 5.7). Duration of operation greater than the 75th percentile (OR, 1.7), obesity
(BMI, 30–35; OR, 3.0), and lack of private health insurance (OR, 1.7) were marginally associated with increased odds of SSI.
conclusions. Incisional SSI after abdominal hysterectomy was associated with increased BMI and blood transfusion. Longer duration
of operation and lack of private health insurance were marginally associated with SSI.
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More than 600,000 hysterectomies are performed annually in
the United States, and more than one-third of women have
undergone the procedure by the age of 60 years.1 In the 2000–
2004 National Hospital Discharge Survey, abdominal hyster-
ectomy accounted for about two-thirds of the procedures,
and approximately one-third of the vaginal hysterectomies
were performed laparoscopically.1 The most common indi-
cations for hysterectomy were uterine leiomyoma, endome-
triosis, and uterine prolapse.1
The pooled rate of surgical site infection (SSI) after ab-
dominal hysterectomy as reported by the National Healthcare
Safety Network for 2006–2007 was 1.7%, and the rate after
vaginal hysterectomy was 0.9%.2 Rates of SSI after hyster-
ectomy reported in individual studies range widely, depend-
ing on the approach and surgical method of hysterectomy
(eg, vaginal, abdominal, or laparoscopic), the indication for
operation, and the use of antimicrobial prophylaxis. SSI rates
also vary depending on the definitions used for surveillance
and whether postdischarge surveillance was used to identify
infections. Recently, Reilly and colleagues reported that twice
as many SSIs after abdominal hysterectomy were recorded
when patients completed questionnaires and interviews to
identify wound signs and symptoms after hospital discharge,
compared with the SSI rate determined from routine sur-
veillance relying on only hospital data.3
Reported SSI rates tend to be higher when the abdominal
approach is used than when the vaginal approach is used and
were higher in the era before presurgical prophylaxis was used
than more recently. Before routine use of prophylactic an-
tibiotic regimens, SSI rates reported for abdominal hyster-
ectomy were 9% or higher in all4-8 but 1 publication.9 During
the past decade, reported SSI rates after abdominal hyster-
1078 infection control and hospital epidemiology november 2009, vol. 30, no. 11
table 1. Characteristics of Operations and Patients at Participating Hospitals
Hospital
Total no.
of hysterectomies
included in study
No. (%) of
abdominal hysterectomies
No. (%) of
cancer-related
hysterectomies
No. (%) of
hysterectomies for
patients without
private health insurance
A 198 80 (40.4) 8 (4.0) 19 (9.6)
B 161 42 (26.1) 18 (11.2) 23 (14.3)
C 198 183 (92.4) 160 (80.8) 81 (40.9)
D 263 240 (91.3) 115 (43.7) 57 (21.7)
Total 820 545 (66.5) 301 (36.7) 180 (22.0)
ectomy have ranged from 1.7% to 11%,10-17 while SSI rates
reported in individual studies after vaginal hysterectomy (ie,
vaginal cuff cellulitis) ranged from 3.1% to 4.8%.12,15,17 Thus,
there seems to be a wider range of SSI rates reported from
individual institutions after abdominal hysterectomy than af-
ter vaginal hysterectomy.
Few studies have determined risk factors for SSI after hys-
terectomy by using standard definitions for SSI and multi-
variable analysis. Risk factors for SSI identified with multi-
variable analysis in previous studies include obesity,7,17 lower
serum albumin level,14 depth of subcutaneous tissue,6 use of
abdominal approach,4,17 open vaginal cuff,7 younger age,4 non-
private patient status,4 and inadequate antimicrobial prophy-
laxis,4,7,14,17 although only 3 studies used standard criteria to
define SSI.6,14,17 It is essential to identify independent risk fac-
tors in order to create a risk index specific to abdominal hys-
terectomy. The National Nosocomial Infection Surveillance
(NNIS) risk index, most commonly used by hospital epide-
miologists, performs better as a risk stratification method be-
tween different types of operations than within an individual
type of operation.18,19 A risk index tailored to abdominal hys-
terectomy would allow for more accurate comparison of SSI
rates across institutions, which would help reveal the reasons
for the wide range of reported SSI rates in individual studies.
We performed a retrospective multihospital analysis of risk
factors for SSI after abdominal hysterectomy as part of a
multicenter surveillance study for the Prevention Epicenter
Program of the Centers for Disease Control and Prevention
(CDC).
methods
Study Population
We conducted a retrospective case-control study of women
who underwent hysterectomy (International Classification of
Diseases, Ninth Revision, Clinical Modification [ICD-9-CM]
procedure codes 68.39, 68.4, 68.6, 68.51, 68.59, and 68.7) at
4 participating CDC Prevention Epicenter Program hospitals
from July 1, 2003, through June 30, 2005. Laparoscopically
assisted abdominal hysterectomies (ICD-9-CM procedure
code 68.31) were excluded. This study was performed in con-
cert with a CDC Prevention Epicenter Program project to
determine the validity of enhanced surveillance based on
ICD-9-CM diagnosis codes and antimicrobial utilization in
order to identify inpatient SSI (D. S. Yokoe, unpublished data,
2008).20 Approval for this study was obtained from all insti-
tutional review boards at the participating centers.
Identification of Case Patients and Control Patients
Initial case patients with SSI within 30 days after operation
were identified at all participating hospitals by means of rou-
tine infection control surveillance. At hospitals where more
than 200 procedures were performed during the study period,
200 patients who did not have SSI identified with routine
surveillance were selected for comparison (by selecting every
nth procedure, where n p total number of procedures di-
vided by 200, rounded to the nearest integer). Medical records
for the original surgical hospitalization and all subsequent
inpatient rehospitalization(s) within 60 days after surgery
were reviewed for case patients and control patients. Signs,
symptoms, and potential risk factors for SSI were abstracted
and entered directly into a Microsoft Access database. Patients
initially selected as control patients on the basis of routine
surveillance but who were subsequently determined to have
an SSI on the basis of CDC/NNIS definitions21 were defined
as case patients in the analyses. Any patients determined to
be prisoners were excluded from evaluation at 1 institution.
Risk Factor Data
Data on potential risk factors collected from case and control
patients included age at date of hysterectomy, weight, height,
type of health insurance, current smoking status, diabetes,
congestive heart failure, indication for hysterectomy (ovarian,
uterine, cervical, or other cancer or not cancer related), pre-
operative glucose level within 24 hours before incision, pre-
operative serum creatinine level, postoperative serum glucose
level within 5 days after operation, postoperative serum cre-
atinine level (during surgical hospitalization), blood trans-
fusion during or after operation (during surgical hospitali-
zation), duration of operation, and type of operation (de-
termined on the basis of ICD-9-CM procedure codes).
Data Analysis
Deidentified data were analyzed with SPSS, version 14.0
(SPSS), and SAS, version 9.1 (SAS Institute). Comparisons
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table 2. Data on Risk Factors for Organ-Space Surgical Site Infection (SSI) after
Hysterectomy
Risk factor
Case patients
(n p 32)
Control patients
(n p 722) P
Categorical risk factors
Insurance status
Private or Medicare 22 (68.8) 641 (88.8)
None 4 (12.5) 24 (3.3) .007
Medicaid 6 (18.8) 57 (7.9) .020
Current smoker 14 (43.8) 106 (14.7) !.001
Congestive heart failure 2 (6.3) 11 (1.5) .102
Diabetes 2 (6.3) 82 (11.4) .566
Cancer 6 (18.8) 258 (35.7) .049
Perioperative blood transfusion 7 (21.9) 103 (14.3) .301
Vaginal hysterectomy 14 (43.8) 261 (36.1) .382
Continuous risk factors
Age, years 45 (33–72) 52 (20–92) .001
Body mass indexa 26.5 (20.5–54.5) 27.5 (15.8–67.3) .228
Duration of operation,b minutes 147 (44–369) 146 (33–476) .769
Serum creatinine level,c mg/dL 0.7 (0.3–6.7) 0.7 (0.3–5.1) .598
Serum glucose level,d mg/dL 129 (80–315) 140 (81–500) .690
note. Data are no. (%) of patients or median values (range).
a Weight in kilograms divided by height in meters squared; 56 control patients were missing values
for weight and/or height.
b One control patient had missing values for operation start and stop times.
c Highest during surgical hospitalization. Nine case patients and 281 control patients were missing
data for creatinine level during the surgical hospitalization.
d Highest from 24 hours before to 5 days after operation. Twenty-three case patients and 435 control
patients were missing data for serum glucose level during the surgical hospitalization.
for categorical variables were made by using the x2 test for
trend, and comparisons for continuous variables were made
by using the Student t test or the Mann-Whitney U test, as
appropriate. All variables with a P value of less than .20 in
the univariate analysis or with a priori clinical importance
were evaluated with stepwise logistic regression. Lack of pri-
vate insurance (ie, Medicaid, Medicare, or no health insur-
ance) was forced into the logistic regression model as a proxy
for socioeconomic status. Missing values for body mass index
(BMI), serum glucose level, and serum creatinine level were
imputed by using multiple imputation with the SAS proce-
dure PROC MI. Ten data sets were generated, each of which
had an imputed value for the variables with missing val-
ues. The 10 data sets were analyzed with PROC LOGISTIC,
and the results were combined for inference with PROC
MIANALYZE.22,23 After identification of the main effects, clin-
ically relevant interactions between variables were tested for
inclusion in the model, with a P value of less than .05 the
criterion for inclusion. Model fit was assessed by using the
C statistic. All tests were 2-tailed, and a P value of less than
.05 was considered to indicate a significant difference.
results
From the 4 participating hospitals, 84 patients were identified
with SSI following abdominal hysterectomy, 13 patients had
organ-space SSI following nonlaparoscopic vaginal hyster-
ectomy (8 patients with vaginal cuff cellulitis and 5 with in-
tra-abdominal infection), and 1 patient had organ-space SSI
(intra-abdominal infection) following laparoscopic vaginal
hysterectomy. Of the 84 patients with SSI after abdominal
hysterectomy, 53 (63%) had a superficial incisional SSI, 13
(15%) had a deep incisional SSI, and 18 (21%) had an organ-
space SSI (5 patients with vaginal cuff cellulitis and 13 patients
with intra-abdominal infection). A total of 722 control pa-
tients without SSI were randomly selected for comparison
with the SSI case patients (261 with vaginal and 461 with
abdominal hysterectomy).
Table 1 shows the case mix of procedures sorted according
to participating hospital. Hospitals C and D had much larg-
er proportions of abdominal hysterectomies compared with
hospitals A and B. Over 80% of the hysterectomies at hospi-
tal C were performed for patients with a diagnosis of cancer,
whereas the proportions of operations performed for patients
with cancer at hospitals A and B were much smaller (4.0%
and 11.2%, respectively). Of 275 vaginal hysterectomies per-
formed at the 4 hospitals, 57 (20.7%) were laparoscopically
assisted.
Univariate associations between demographic and clinical
characteristics of patients with or without organ-space SSI
after hysterectomy are shown in Table 2, and univariate as-
sociations between these characteristics of patients with or
without incisional SSI (superficial incisional and deep inci-
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table 3. Data on Risk Factors for Incisional Surgical Site Infection (SSI) after Abdominal Hysterectomy
Risk factor
Case patients
with deep
incisional SSI
(n p 13)
Case patients
with superficial
incisional SSI
(n p 53)
Control patients
(n p 461) P a
Categorical risk factors
Insurance status
Private or Medicare 9 (69.2) 37 (69.8) 402 (87.2) .002
None 2 (15.4) 5 (9.4) 17 (3.7)
Medicaid 2 (15.4) 11 (20.8) 42 (9.1)
Current smoker 4 (30.8) 11 (20.8) 72 (15.6) .097
Congestive heart failure 0 3 (5.7) 10 (2.2) .483
Diabetes 6 (46.2) 14 (26.4) 67 (14.5) !.001
Cancer 8 (61.5) 29 (54.7) 232 (50.3) .333
Perioperative blood transfusion 5 (38.5) 22 (41.5) 89 (19.3) !.001
Continuous risk factors
Age, years 61 (29–80) 50 (34–88) 51 (20–92) .254
Body mass indexb 33.3 (25.1–64.8) 37.6 (15.7–68.2) 29.7 (15.8–67.3) !.001
Duration of operation, minutes, mean  SD 216.6  73.1 190.6  75.1 154.4  64.9 !.001c
Serum creatinine level, mg/dL 0.93 (0.7–1.7) 0.80 (0.5–3.1) 0.71 (0.3–5.1) .001d
Serum glucose level, mg/dL 189 (103–399) 156 (108–500) 141 (82–500) .005e
note. Data are no. (%) of patients or median values (range), unless otherwise indicated. SD, standard deviation.
a The x2 test for trend or the Kruskal-Wallis test were used, as appropriate.
b Weight in kilograms divided by height in meters squared; 2 case patients and 24 control patients were missing values for weight
and/or height.
c One-way analysis of variance.
d Ninety-two patients were missing values for serum creatinine level.
e Ninety-four patients were missing values for serum glucose level.
sional) after abdominal hysterectomy are shown in Table 3.
Women with organ-space SSI were younger, more likely to
smoke, and less likely to have private health insurance or
cancer as an indication for the operation than were women
without SSI (Table 2). Women with incisional SSI after ab-
dominal hysterectomy had a higher median BMI and were
more likely to have diabetes and to require perioperative
blood transfusion than were women without SSI after ab-
dominal hysterectomy (Table 3). Women with incisional SSI
after abdominal hysterectomy were also more likely to lack
private health insurance than were women without SSI after
abdominal hysterectomy.
In univariate analysis, the maximum perioperative serum
glucose levels and creatinine levels were significantly higher
in women with deep incisional SSI and superficial incisional
SSI than in women without SSI after abdominal hysterectomy
(Table 3). Duration of operation was also significantly longer
for women with deep incisional SSI and superficial incisional
SSI than for women without SSI after abdominal hysterec-
tomy (Table 3).
For 4 of the 64 women with incisional SSI and perioperative
glucose level measurements available for analysis, the highest
glucose level measurement of the perioperative period was
recorded prior to operation. Of the remaining 60 women
with a postoperative glucose level measurement available, 12
had postoperative serum glucose level measurements that
could have been obtained within 2 days before the diagnosis
of incisional SSI. Of these 12 women, 7 had a maximum
postoperative serum glucose level measurement of more than
150 mg/dL within 5 days of the operation. Among these 7
subjects, the date of maximum postoperative glucose level
measurement was available for 5; for all 7 women, these values
were obtained within 48 hours after operation and at least 2
days prior to the diagnosis of incisional SSI.
Independent risk factors for incisional SSI were identified
by using multivariable logistic regression. To include all sub-
jects in the analysis, multiple imputation was used to create
values for missing BMI, serum glucose level, and serum cre-
atinine level. The risk factors retained in the final model are
shown in Table 4. Independent risk factors included periop-
erative blood transfusion and morbid obesity (BMI, 135).
Duration of operation greater than the 75th percentile, lack
of private health insurance, and obesity (BMI, 30–35) were
marginally associated with increased risk of incisional SSI. In
a preliminary multivariable model that excluded patients with
missing glucose test results, a perioperative serum glucose
level of more than 180 mg/dL was marginally associated with
increased risk of incisional SSI ( ). In the final mul-Pp .056
tivariable model, after missing values were imputed, a per-
ioperative serum glucose level of more than 180 mg/dL was
no longer associated with significantly increased odds of SSI
( ).Pp .145
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table 4. Data on Independent Risk Factors for Incisional Surgical Site Infection after
Abdominal Hysterectomy
Risk factor
Adjusted odds ratio
(95% confidence interval) P
Perioperative blood transfusion 2.4 (1.4–4.4) .003
Duration of operation greater than 75th percentile 1.7 (1.0–3.0) .074
Medicaid or no health insurance 1.7 (0.9–2.9) .076
Body mass index
!25 Reference
25–30 2.4 (0.8–7.2) .104
30–35 3.0 (1.0–9.6) .058
135 5.7 (2.1–15.6) .001
note. Model C statistic, 0.729.
discussion
Identification of independent risk factors for SSI is essential
for the development of operation-specific risk stratification
indices. In this multicenter study performed at 4 hospitals in
the CDC Prevention Epicenter Program, we identified 2 in-
dependent risk factors for incisional SSI after abdominal hys-
terectomy: blood transfusion and morbid obesity. Duration
of operation greater than the 75th percentile, obesity, and
lack of private health insurance were marginally associated
with increased odds of SSI in the multivariable analysis.
We determined independent risk factors for only abdom-
inal incisional SSI in this study, since in univariate analysis,
the risk factors for organ-space SSI seemed to be different.
Crude risk factors for organ-space SSI included lack of private
health insurance, current smoking, and younger age, while
cancer as the indication for operation was associated with a
significantly lower risk of organ-space SSI. Since these risk
factors were substantially different from the incisional SSI
risk factors, in subsequent analyses, we focused on risk factors
for superficial incisional and deep incisional SSI after ab-
dominal hysterectomy.
Morbid obesity was associated with the greatest odds of
incisional SSI, with a dose-response relationship between risk
and increased BMI. Obesity has been found to be a risk factor
for SSI by many investigators, in particular after abdominal
and gynecologic operations.24 Obesity has also been shown
to be independently associated with SSI after hysterectomy
(vaginal or abdominal)17 and, specifically, after abdominal
hysterectomy.6,7 In our current study, undergoing a blood
transfusion was associated with significantly increased odds
of incisional SSI. Persson and colleagues found blood loss of
more than 1 L during surgery to be a risk factor for SSI,8
and Shapiro and colleagues also found blood loss to be as-
sociated with increased risk of SSI in univariate analysis.4 Both
of these studies included vaginal and abdominal hysterec-
tomies, and neither included blood loss in a multivariable
model to control for confounding factors. We and others have
previously noted that excessive blood loss that necessitates
transfusion is associated with increased risk of SSI after a
variety of operations,25-28 although whether this association is
due to the underlying anemia, to transfusion-related im-
munomodulation,29 or to residual confounding is not clear.
Longer duration of operation and lack of private health
insurance were marginally associated with increased odds of
SSI after abdominal hysterectomy. Duration of operation
greater than the 75th percentile is part of the standard NNIS
risk index. It is not clear whether the risk associated with
longer operations is truly due to the length of the operation
or whether longer duration is at least in part a proxy for the
complexity of the operation or for the skill of the operating
staff.
We used lack of private health insurance as a proxy for
low socioeconomic status in this study. Previously, Shapiro
et al found that being a clinic patient (as opposed to being
a private patient) was an independent risk factor for SSI after
vaginal or abdominal hysterectomy.4 In general, lower socio-
economic status is considered to be a risk factor for infection
after a gynecologic operation,30 but the reasons for this as-
sociation are not known.
In univariate analysis, there was a trend toward increasing
perioperative serum glucose levels in patients with superficial
incisional SSI and deep incisional SSI, compared with women
with no SSI after abdominal hysterectomy. We used a peri-
operative window of 24 hours before operation to 5 days
after operation for assessment of maximum serum glucose
level measurements. It is unlikely that active infection could
have explained the high glucose values, since the onset of
incisional SSI occurred at least 2 days after the highest serum
glucose level in all but 2 patients (with missing dates of glu-
cose measurement). Serum glucose level did not remain as
an independent risk factor in the multivariable model. In
part, this may be due to the relatively large number of patients
without laboratory results for serum glucose level during the
perioperative period. We used multiple imputation to impute
a set of plausible glucose values that represent the uncertainty
about the correct value, but it is possible that a higher glucose
level would have remained associated with an increased risk
of incisional SSI if serum glucose level measurements had
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been available for all patients. Determination of the risk of
incisional SSI associated with perioperative hyperglycemia
will require more complete glucose testing of patients at risk
for hyperglycemia (eg, with obesity and/or family history of
diabetes) before and after operation. Given the increasingly
widespread epidemics of obesity and diabetes in the United
States, there are increasing numbers of hospitalized patients
with undiagnosed and untreated diabetes.31,32 Earlier and more
accurate diagnosis of diabetes before surgery is necessary. Ad-
ditional studies to evaluate the relationship between periop-
erative glucose control and SSI and wound complications are
needed.
The limitations of this study include the retrospective ob-
servational nature of the study, which precluded collecting
data on some potential risk factors for SSI (eg, adequacy of
preoperative skin antisepsis and operative hemostasis). In ad-
dition, the collection of data from 4 hospitals necessitated
restricting the investigation to a relatively small number of
risk factors to ensure that data collection was as complete
and accurate as possible. Also, the surveillance strategy that
we used excluded SSI diagnosed and treated solely in out-
patient settings. Because we reviewed only hospital records,
it is possible that some individuals classified as uninfected
control patients had SSI, resulting in misclassification of the
outcome, which would potentially result in bias of results
toward the null.
The advantages of this study included its multicenter na-
ture, with collection of data from patients admitted for hys-
terectomy to 4 academic hospitals. Inclusion of data from a
variety of different types of hospital, including hospitals with
different patient populations with different indications for
hysterectomy, expands the generalizability of the results to
other academic medical centers. In addition, we used stan-
dardized definitions for SSI and enhanced surveillance to
identify infections during the hospitalization for surgery and
during rehospitalization. We focused our analysis on the risk
factors for incisional SSI after abdominal hysterectomy, since
the risk factors associated with organ-space SSI seem to differ
from the risk factors for incisional SSI after hysterectomy.
In summary, we identified morbid obesity and perioper-
ative blood transfusion as independent risk factors for su-
perficial incisional and deep incisional SSI after abdominal
hysterectomy. Obesity, longer duration of operation, and lack
of private health insurance were marginally associated with
increased odds of incisional SSI. Additional studies are needed
to determine the association of perioperative hyperglycemia
with SSI after abdominal hysterectomy. The risk factors iden-
tified in this study can be used in the future to create a risk
stratification index specific for abdominal hysterectomy and
incisional SSI.
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